Top Vaccines companies in Switzerland by Debt to Equity Ratio
Switzerland
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
0.63
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
| 2 |
0.30
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
| 3 |
0.02
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
| 4 |
0.02
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
| 5 |
0.01
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
| 6 |
-0.84
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
| 7 |
-12.86
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
Frequently Asked Questions
-
Which Vaccines company in Switzerland has the highest Debt to Equity Ratio ?
The Vaccines company in Switzerland with the highest Debt to Equity Ratio is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at 0.63.
-
Which Vaccines company in Switzerland has the lowest Debt to Equity Ratio ?
The Vaccines company in Switzerland with the lowest Debt to Equity Ratio is Basilea Pharmaceutica AG (Swiss Stock Exchange: BSLN.SW) at -12.86.
-
What are the top 10 Vaccines companies in Switzerland by Debt to Equity Ratio ?
The top 10 Vaccines companies in Switzerland by Debt to Equity Ratio are Sandoz Group AG, PolyPeptide Group AG, AC Immune SA, Molecular Partners AG, MoonLake Immunotherapeutics, ADC Therapeutics SA and Basilea Pharmaceutica AG.
-
What are the bottom 10 Vaccines companies in Switzerland by Debt to Equity Ratio ?
The bottom 10 Vaccines companies in Switzerland by Debt to Equity Ratio are Basilea Pharmaceutica AG, ADC Therapeutics SA, MoonLake Immunotherapeutics, Molecular Partners AG, AC Immune SA, PolyPeptide Group AG and Sandoz Group AG.
